Profile data is unavailable for this security.
About the company
Kindstar Globalgene Technology Inc is a China-based investment holding company principally engaged in the provision of clinical testing services. The Company operates nine segments. Hematology Testing segment includes testing services related to blood diseases. Genetic Diseases and Rare Diseases segment includes testing services from the rare disease. Infectious Diseases segment includes testing services from the infection department. Oncology segment includes testing related to oncology diseases. Neurology segment includes testing services related to neurological diseases undertaken by the Group. Maternity-related Diseases segment includes testing services related to maternity. COVID-19 Related Testing segment includes testing services related to COVID-19. Routine Testing segment conducts routine tests for the doctors’ daily diagnoses. The Others segment includes testing services for research and development (R&D) projects and others and miscellaneous services.
- Revenue in HKD (TTM)1.05bn
- Net income in HKD10.18m
- Incorporated2007
- Employees3.19k
- LocationKindstar Globalgene Technology IncEast Lake High Tech ZoneBiolake D2-1, 666 Gaoxin RoadWUHAN ChinaCHN
- Websitehttps://www.kindstar.com.cn/
Mergers & acquisitions
Acquired company | 9960:HKG since announced | Transaction value |
---|---|---|
Anchordx Inc | 8.26% | 31.30m |